AC
ANAB icon

Athanor Capital’s AnaptysBio ANAB Stock Holding History

Athanor Capital’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-12,150
Closed -$179K – 697
2020
Q3 		$179K Sell
12,150
-11,085
-48% -$200K 0.01% 502
2020
Q2 		$519K Buy
+23,235
New +$425K 0.03% 297
2019
Q3 		– Sell
-3,900
Closed -$220K – 205
2019
Q2 		$220K Buy
+3,900
New +$281K 0.03% 126

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Athanor Capital's ANAB Position: Q4 2020 in Review

Athanor Capital sold out of AnaptysBio (ANAB) in Q4 2020, closing a stake of 12,150 shares — an estimated $179K sold.

Athanor Capital first reported a position in ANAB in Q2 2019 and held it in 3 quarters. The position peaked at $519K in Q2 2020. 136 funds tracked by Wall St. Rank hold ANAB as of Q4 2020.

  • Athanor Capital reported no remaining AnaptysBio position as of Q4 2020 after selling out during the quarter.
  • Athanor Capital sold 12,150 AnaptysBio shares in Q4 2020, an estimated $179K.
  • Athanor Capital first reported a position in AnaptysBio in Q2 2019 and held it in 3 quarters.
  • Athanor Capital's AnaptysBio position peaked at $519K in Q2 2020.
  • 136 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2020.

Based on Athanor Capital's 13F filing for Q4 2020, filed 16 Feb 2021.